{"id":"https://openalex.org/G7635306544","display_name":"Development of Technologies for Efficient In Vivo Prime Editing","description":"NARRATIVE Genome editing technologies provide novel opportunities to advance basic research and treat human diseases but approaches that use active nucleases to edit DNA can induce undesired and deleterious effects in the genome, which can reduce their therapeutic potential. Prime editors are a recently emerged gene-editing variant capable of introducing precise modifications to DNA, with minimal damage to the genome. This proposal is focused on creating an integrative prime editing toolkit that will provide investigators with technologies that will enable their use in vivo, improve their specificity and streamline their design and implementation, thereby advancing the applications of this methodology in biotechnology and biomedicine.","funder_award_id":"R01GM141296","funder":{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","doi":"https://doi.org/10.13039/100000057"},"funded_outputs":["https://openalex.org/W4206365019","https://openalex.org/W4291222817","https://openalex.org/W4313480345","https://openalex.org/W4382787256","https://openalex.org/W4385325776","https://openalex.org/W4387639698","https://openalex.org/W4388116190","https://openalex.org/W4400428152","https://openalex.org/W4404794577","https://openalex.org/W4406152318","https://openalex.org/W4411237752","https://openalex.org/W7155486518"],"funded_outputs_count":12,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":null,"currency":"USD","amount_usd":null,"amount_usd_basis":null,"recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"research","funder_scheme":"R01","start_date":"2021-04-01","end_date":"2026-02-28","start_year":2021,"end_year":2026,"landing_page_url":"https://reporter.nih.gov/project-details/10580008","doi":null,"provenance":"nih_exporter","lead_investigator":{"given_name":"PABLO","family_name":"PEREZ-PINERA","orcid":null,"role_start":null,"affiliation":{"name":"UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN","country":"UNITED STATES","ids":null},"author":{"id":"https://openalex.org/A5002394616","display_name":"Pablo P\u00e9rez\u2010Pi\u00f1era","orcid":"https://orcid.org/0000-0002-9167-0004"},"institutions":[{"id":"https://openalex.org/I157725225","display_name":"University of Illinois Urbana-Champaign","ror":"https://ror.org/047426m28","country_code":"US","type":"education","lineage":["https://openalex.org/I157725225"]}]},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G7635306544","primary_topic":{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.9995,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.9995,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12610","display_name":"RNA regulation and disease","score":0.0005,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prime-editing","display_name":"prime editing","score":0.978},{"id":"https://openalex.org/keywords/in-vivo-genome-editing","display_name":"in vivo gene editing","score":0.825},{"id":"https://openalex.org/keywords/genome-editing","display_name":"genome editing","score":0.423},{"id":"https://openalex.org/keywords/editing-specificity","display_name":"editing specificity","score":0.542},{"id":"https://openalex.org/keywords/dna-modification","display_name":"DNA modification","score":0.383},{"id":"https://openalex.org/keywords/crispr-cas9","display_name":"CRISPR/Cas9","score":0.621}],"sustainable_development_goals":[],"institution_awarded":[{"id":"https://openalex.org/I157725225","display_name":"University of Illinois Urbana-Champaign","ror":"https://ror.org/047426m28","country_code":"US","type":"education","lineage":["https://openalex.org/I157725225"]}],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-10-09T19:56:01.000Z"}
